Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick R Appelbaum

Showing results (1-10 of 339) with videos related to

Pageof 34
Sort By:
Best Practice & Research. Clinical Haematology|November 24, 2018
Hematopoietic cell transplantation as treatment of patients with acute myeloid leukemia with measurable residual disease after consolidation therapyFrederick R Appelbaum
Oncology (Williston Park, N.Y.)|May 31, 2011
What pediatrics can teach usFrederick R Appelbaum
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2003
Use of granulocyte colony-stimulating factor following hematopoietic cell transplantation: does haste make waste?Frederick R Appelbaum
The New England Journal of Medicine|October 19, 2012
Pursuing the goal of a donor for everyone in needFrederick R Appelbaum
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
Innovations in preparative regimens for autologous hematopoietic cell transplantationFrederick R Appelbaum
Hematology. American Society of Hematology. Education Program|December 17, 2008
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia when a matched related donor is not availableFrederick R Appelbaum
Best Practice & Research. Clinical Haematology|December 2, 2008
What is the impact of hematopoietic cell transplantation (HCT) for older adults with acute myeloid leukemia (AML)?Frederick R Appelbaum
Best Practice & Research. Clinical Haematology|November 23, 2015
Hematopoietic cell transplantation for adults with acute myeloid leukemia with minimal residual diseaseFrederick R Appelbaum
Best Practice & Research. Clinical Haematology|November 21, 2017
Impact of allogeneic hematopoietic cell transplantation on the outcome of older patients with acute myeloid leukemiaFrederick R Appelbaum
Leukemia|October 9, 2024
Offering patients a second chance: what is the minimum cure rate needed to justify allogeneic hematopoietic cell transplantation?Frederick R Appelbaum
Pageof 34

Showing results (1-10 of 339) with videos related to

Sort By:
Pageof 34
Best Practice & Research. Clinical Haematology|November 24, 2018
Hematopoietic cell transplantation as treatment of patients with acute myeloid leukemia with measurable residual disease after consolidation therapyFrederick R Appelbaum
Oncology (Williston Park, N.Y.)|May 31, 2011
What pediatrics can teach usFrederick R Appelbaum
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 24, 2003
Use of granulocyte colony-stimulating factor following hematopoietic cell transplantation: does haste make waste?Frederick R Appelbaum
The New England Journal of Medicine|October 19, 2012
Pursuing the goal of a donor for everyone in needFrederick R Appelbaum
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
Innovations in preparative regimens for autologous hematopoietic cell transplantationFrederick R Appelbaum
Hematology. American Society of Hematology. Education Program|December 17, 2008
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia when a matched related donor is not availableFrederick R Appelbaum
Best Practice & Research. Clinical Haematology|December 2, 2008
What is the impact of hematopoietic cell transplantation (HCT) for older adults with acute myeloid leukemia (AML)?Frederick R Appelbaum
Best Practice & Research. Clinical Haematology|November 23, 2015
Hematopoietic cell transplantation for adults with acute myeloid leukemia with minimal residual diseaseFrederick R Appelbaum
Best Practice & Research. Clinical Haematology|November 21, 2017
Impact of allogeneic hematopoietic cell transplantation on the outcome of older patients with acute myeloid leukemiaFrederick R Appelbaum
Leukemia|October 9, 2024
Offering patients a second chance: what is the minimum cure rate needed to justify allogeneic hematopoietic cell transplantation?Frederick R Appelbaum
Pageof 34